Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZD-2138 is a potent and selective specific inhibitor of 5-lipoxygenase (5-LOX) that inhibits allergen-induced pulmonary bronchoconstriction and reduces neurally-induced fast-acting kallikrein-ergic constriction of isolated airways in guinea pigs.ZD-2138 can be used for the treatment of asthma disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
5 mg | In stock | $ 320.00 | |
10 mg | In stock | $ 470.00 | |
25 mg | In stock | $ 772.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,460.00 | |
500 mg | In stock | $ 2,920.00 |
Description | ZD-2138 is a potent and selective specific inhibitor of 5-lipoxygenase (5-LOX) that inhibits allergen-induced pulmonary bronchoconstriction and reduces neurally-induced fast-acting kallikrein-ergic constriction of isolated airways in guinea pigs.ZD-2138 can be used for the treatment of asthma disease. |
In vitro | The 5-lipoxygenase inhibitor ZD-2138 (1 μM) significantly inhibited these neurally mediated tachykinergic contractions, by approximately 50%, yet had no effect on the contractions evoked by stimulating tachykinergic fibers in an action potential-independent fashion with capsaicin or by exogenously applied neurokinin A.[1] |
Synonyms | Ici-D2138 |
Molecular Weight | 397.44 |
Formula | C23H24FNO4 |
CAS No. | 140841-32-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (37.74 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZD-2138 140841-32-3 Metabolism Lipoxygenase Ici-D2138 Ici-D-2138 Ici-D 2138 ZD2138 ZD 2138 inhibitor inhibit